Serengeti Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-15,000
| Closed | -$1.51M | – | 51 |
|
|
2021
Q3 | $1.51M | Buy |
+15,000
| New | +$1.51M | 0.05% | 13 |
|
|
2021
Q2 | – | Sell |
-25,000
| Closed | -$2.49M | – | 39 |
|
|
2021
Q1 | $2.49M | Hold |
25,000
| – | – | 1.09% | 5 |
|
|
2020
Q4 | $3.09M | Sell |
25,000
-3,000
| -11% | -$371K | 1.01% | 4 |
|
|
2020
Q3 | $2.73M | Buy |
28,000
+23,000
| +460% | +$2.24M | 0.85% | 7 |
|
|
2020
Q2 | $780K | Sell |
5,000
-10,000
| -67% | -$1.56M | 0.27% | 8 |
|
|
2020
Q1 | $2.17M | Buy |
+15,000
| New | +$2.17M | 2.25% | 9 |
|